公司资料
Mirum Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- MIRM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
96.72 USD (+0.43%)
收盘价
最后更新: 2026年8月24日
5.62B USD
市值
股价为何变动
As of Aug 24, 2026, MIRM closed up 0.43% at $96.72. No new same-company headline was identified in the current news window.
公司概览
业务概览
Mirum Pharmaceuticals is a rare-disease company focused on cholestatic and liver disorders. Its commercial profile is built around specialized therapies for pediatric and orphan indications.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Mirum sits in specialty biopharma.
商业模式特征
The company combines product revenue with label expansion and pipeline growth in liver disease.
生物医药行业定位
Mirum is a durable rare-disease name whose stock moves on commercial execution and franchise expansion.
未来催化剂
- Mirum's catalysts are Livmarli growth, liver-disease expansion, and any new rare-cholestatic label or commercial step that widens the franchise. The stock improves if the rare-disease base keeps compounding into a broader franchise.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。